Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Takeda OncologyTakeda Oncology
VS
Astellas PharmaAstellas Pharma
Takeda Oncology

Takeda Oncology

40 Landsdowne St., Cambridge, MA, 02139, US

Last Update: 28/02/2026

View Profile
Between 750 and 799
http://www.takedaoncology.com
764/1000Fair

Takeda Oncology is the Global Oncology Business Unit of Takeda Pharmaceutical Company Limited. At Takeda, we are united by our aspiration to cure cancer. Drawing on decades of leadership in oncology, we strive to develop innovative treatments that make a difference in...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:1,665
Subsidiaries:6
12-month incidents
0
Known data breaches
0
Attack type number
0
Astellas Pharma

Astellas Pharma

2-5-1, Nihonbashi-Honcho, Chuo-Ku, Tokyo, JP, 103-8411

Last Update: 05/04/2026

View Profile
Between 800 and 849
http://www.astellas.com/
802/1000Good

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and develo...

NAICS:3254
NAICS Definition:Pharmaceutical and Medicine Manufacturing
Employees:12,110
Subsidiaries:1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Takeda Oncology

Takeda Oncology

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
Astellas Pharma

Astellas Pharma

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Takeda Oncology in 2026.

Incidents

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Astellas Pharma in 2026.

Incidents

Incident History - Takeda Oncology (X = Date, Y = Severity)

Takeda Oncology cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - Astellas Pharma (X = Date, Y = Severity)

Astellas Pharma cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Takeda Oncology

Takeda Oncology

Incidents
No explicit notable incidents reported.
Astellas Pharma

Astellas Pharma

Incidents
No explicit notable incidents reported.

FAQ

Between Takeda Oncology company and Astellas Pharma company, which one has the best AI Cybersecurity Score ?
Between Takeda Oncology company and Astellas Pharma company, which one has experienced more cyber incidents in the past ?
Between Takeda Oncology company and Astellas Pharma company, which one has experienced more cyber incidents this year ?
Between Takeda Oncology company and Astellas Pharma company, which one has experienced at least one ransomware attack ?
Between Takeda Oncology company and Astellas Pharma company, which one has experienced at least one data breach ?
Between Takeda Oncology company and Astellas Pharma company, which one has experienced at least one targeted cyberattack ?
Between Takeda Oncology company and Astellas Pharma company, which one has experienced at least one vulnerability ?
Between Takeda Oncology company and Astellas Pharma company, which one holds the most compliance certifications ?
Between Takeda Oncology company and Astellas Pharma company, which one holds the fewest compliance certifications ?
Between Takeda Oncology company and Astellas Pharma company, which one has the most subsidiaries ?
Between Takeda Oncology company and Astellas Pharma company, which one has the largest number of employees ?
Between Takeda Oncology and Astellas Pharma, which company holds both SOC 2 Type 1 certifications ?
Between Takeda Oncology and Astellas Pharma, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Takeda Oncology or Astellas Pharma ?
Which company is PCI DSS compliant - Takeda Oncology or Astellas Pharma ?
Between Takeda Oncology and Astellas Pharma, which company complies with HIPAA regulations for healthcare data ?
Between Takeda Oncology and Astellas Pharma, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-57100
SUMMARY

Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-54998
SUMMARY

Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-45499
SUMMARY

Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-41106
SUMMARY

Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.3)
CVSS3
Base Score: 9.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-26145
SUMMARY

Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 4.8)
CVSS3
Base Score: 4.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES